BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15700330)

  • 21. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions.
    Beaton C; Cochlin D; Kumar N
    Eur J Surg Oncol; 2010 Jan; 36(1):43-6. PubMed ID: 19709846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. US characterization of focal hepatic lesions with intermittent high-acoustic-power mode and contrast material.
    Quaia E; Bertolotto M; Calderan L; Mosconi E; Mucelli RP
    Acad Radiol; 2003 Jul; 10(7):739-50. PubMed ID: 12862283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of focal liver lesions with contrast-enhanced ultrasound.
    Piscaglia F; Lencioni R; Sagrini E; Pina CD; Cioni D; Vidili G; Bolondi L
    Ultrasound Med Biol; 2010 Apr; 36(4):531-50. PubMed ID: 20350680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical value of contrast-enhanced ultrasonography in the characterization of focal liver lesions: a prospective multicenter trial.
    Wang WP; Wu Y; Luo Y; Li R; Zhou XD; Zhang J; Qian CW; Tan XY; Xu QH; Wang Y; Yuan JJ
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):370-6. PubMed ID: 19666405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
    Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue.
    Bleuzen A; Tranquart F
    Eur Radiol; 2004 Oct; 14 Suppl 8():P53-62. PubMed ID: 15700333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound.
    Solbiati L; Ierace T; Tonolini M; Cova L
    Eur J Radiol; 2004 Jun; 51 Suppl():S19-23. PubMed ID: 15311434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of enhancement in contrast ultrasound: a tool for monitoring of therapies in liver metastases.
    Krix M
    Eur Radiol; 2005 Dec; 15 Suppl 5():E104-8. PubMed ID: 18637237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients.
    Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A
    Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent.
    Xu HX; Liu GJ; Lu MD; Xie XY; Xu ZF; Zheng YL; Liang JY
    J Clin Ultrasound; 2006; 34(6):261-72. PubMed ID: 16788957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of focal liver lesions with contrast enhanced ultrasonography.
    Dietrich CF
    Eur J Radiol; 2004 Jun; 51 Suppl():S9-17. PubMed ID: 15234021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of focal liver lesions with a new ultrasound contrast agent using continuous low acoustic power imaging: comparison with contrast enhanced spiral CT.
    Passamonti M; Vercelli A; Azzaretti A; Rodolico G; Calliada F
    Radiol Med; 2005 Apr; 109(4):358-69. PubMed ID: 15883520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
    Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
    Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Contrast-enhanced "low MI real-time" sonography for the assessment of the malignancy of focal liver lesions].
    Strunk H; Börner N; Stuckmann G; Fröhlich E; Hadizadeh D
    Rofo; 2005 Oct; 177(10):1394-404. PubMed ID: 16170709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid focal liver lesions indeterminate by contrast-enhanced CT or MR imaging: the added diagnostic value of contrast-enhanced ultrasound.
    Quaia E
    Abdom Imaging; 2012 Aug; 37(4):580-90. PubMed ID: 21894508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A)--comparison of SonoVue and Levovist in HCC.
    von Herbay A; Haeussinger D; Gregor M; Vogt C
    Ultraschall Med; 2007 Apr; 28(2):168-75. PubMed ID: 17447216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.